BGI Shenzhen

BGI (Chinese: 华大基因; pinyin: Huádà Jīyīn), known as the Beijing Genomics Institute prior to 2008, is one of the world’s premier genome sequencing centers. Its sequencing output is expected to soon surpass the equivalent of more than 15,000 human genomes per year. BGI will receive US$1.5 billion in “collaborative funds” over the next 10 years from the China Development Bank. BGI is producing de novo, resequenced genomes, RNA-Seq, Epigenomics, Metagenomics and Proteomics at such a high volume that genomes and research of significant impact are not listed here. For a complete reference of BGI's contribution to science, read a list of genomes sequenced at the bottom of this article.

Website
http://www.genomics.cn
Wikipedia
http://en.wikipedia.org/wiki/Beijing_Genomics_Institute

Some content from Wikipedia, licensed under CC BY-SA

Subscribe to rss feed

Oncology & Cancer

Study confirms accuracy of its NIFTY in nearly 147,000 pregnancies

BGI has published a study tracking the clinical performance of its whole genome sequencing-based non-invasive prenatal test (the NIFTY test) in nearly 147,000 pregnancies, the largest such study to date. The results showed ...

Genetics

BGI presents a high-quality gene catalog of human gut microbiome

Researchers from BGI, working within the Metagenomics of the Human Intestinal Tract (MetaHIT) project, and in collaboration with other institutions around the world , have established the highest quality integrated gene set ...

page 1 from 2